Wealthcare Advisory Partners LLC Biogen Inc. Transaction History

Wealthcare Advisory Partners LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $2,052 - $2,338	8 Added 1.0%	809 $224,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $202,204 - $245,682	801 New	801 $221,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $165,266 - $215,525	-584 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $9,065 - $14,514	-35 Reduced 5.65%	584 $202,000
Q1 2021 Apr 30, 2021	BUY	$242.95 - $284.63 $150,386 - $176,185	619 New	619 $173,000
Q2 2020 Jul 29, 2020	SELL	$258.66 - $342.55 $130,105 - $172,302	-503 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$219.29 - $241.72 $17,543 - $19,337	-80 Reduced 13.72%	503 $118,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $20,601 - $24,552	80 Added 15.9%	583 $169,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $76,738 - $108,533	295 Added 141.83%	503 $138,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1,538 - $1,722	5 Added 2.46%	208 $66,000
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $57,073 - $66,927	203	203 $64,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.